8.06
price down icon0.25%   -0.02
after-market Dopo l'orario di chiusura: 8.07 0.010 +0.12%
loading

Vigil Neuroscience Inc Borsa (VIGL) Ultime notizie

pulisher
03:47 AM

What analysts say about Vigil Neuroscience Inc. stockFree Investment Community - jammulinksnews.com

03:47 AM
pulisher
03:22 AM

What drives Vigil Neuroscience Inc. stock priceGame-changing capital returns - jammulinksnews.com

03:22 AM
pulisher
07:23 AM

Is Vigil Neuroscience Inc. a good long term investmentStrong return on assets - jammulinksnews.com

07:23 AM
pulisher
03:10 AM

Vigil Neuroscience Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com

03:10 AM
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period - Investing.com Australia

Jul 17, 2025
pulisher
Jul 15, 2025

How Vigil Neuroscience Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Vigil Neuroscience Inc. stock attracts strong analyst attention10x Potential Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Vigil Neuroscience Inc. stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80 - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc.VIGL - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

TREM2 agonists reported in Vigil Neuroscience patents - BioWorld MedTech

Jul 14, 2025
pulisher
Jul 09, 2025

Vigil Neuroscience (NASDAQ:VIGL) Stock Price Up 0.4% – Here’s What Happened - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: TASK, VIGL, STRM, and CHTR - The Malaysian Reserve

Jul 04, 2025
pulisher
Jun 30, 2025

Vigil Neuroscience Announces Special Meeting for Sanofi Merger Vote - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

VIGL to Be Acquired by Sanofi for $8 Cash + $2 CVR; Vote Aug 4 2025 | VIGL SEC FilingForm DEFM14A - Stock Titan

Jun 30, 2025
pulisher
Jun 25, 2025

Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High? - Nasdaq

Jun 25, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet - MSN

Jun 09, 2025
pulisher
Jun 05, 2025

Vigil Neuroscience: ALSP Data Doesn't Deliver, But Sanofi Purchase Remains Intact (VIGL) - Seeking Alpha

Jun 05, 2025
pulisher
Jun 05, 2025

Vigil Neuroscience fails in mid-stage study for lead asset - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders - marketscreener.com

Jun 05, 2025
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Capitalizzazione:     |  Volume (24 ore):